
Article 1 
The health claim set out in Annex I to this Regulation may be made on foods on the Great Britain market in compliance with the conditions set out in that Annex.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Article 2 
The health claims set out in the Annex II to this Regulation may not be made on foods on the Great Britain market.
Article 3 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
...
ANNEX I
Application — Relevant provisions of Regulation (EC) No 1924/2006 Applicant — Address Nutrient, substance, food or food category Claim Conditions of use of the claim Conditions and/or restrictions of use of the food and/or additional statement or warning EFSA opinion reference
Article 14(1)(a) health claim referring to a reduction of a disease risk Danone France, 150 Bd Victor Hugo, 93589 Saint-Ouen Cedex, France Plant sterols/Plant stanol esters Plant sterols and plant stanol esters have been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease. Information to the consumer that the beneficial effect is obtained with a daily intake of 1,5-3 g plant sterols/stanols. Reference to the magnitude of the effect may only be made for foods within the following categories: yellow fat spreads, dairy products, mayonnaise and salad dressings. When referring to the magnitude of the effect, the range ‘7 % to 10 %’ for foods that provide a daily intake of 1,5-2,4 g plant sterols/stanols or the range ‘10 % to 12,5 %’ for foods that provide a daily intake of 2,5-3 g plant sterols/stanols and the duration to obtain the effect ‘in 2 to 3 weeks’ must be communicated to the consumer.  Q-2008-779Q-2009-00530 and Q-2009-00718Q-2011-01241
ANNEX II
Application — Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference
Article 14(1)(a) health claim referring to a reduction of a disease risk Lycopene-whey complex Lycopene-whey complex prevents oxidative damage of plasma lipoproteins, which reduces the build up of arterial plaques and reduces the risk of heart disease, stroke and other clinical complications of atherosclerosis Q-2008-703
Article 14(1)(a) health claim referring to a reduction of a disease risk BimunoTM (BGOS) Prebiotic Regular consumption of BimunoTM (BGOS) Prebiotic helps to protect against the bad bacteria than can cause the travellers’ diarrhoea Q-2009-00232